Bayer Pay-For-Delay Deal A Taste Of Post-Actavis Climate

Bayer Corp.’s $74 million payout last week to escape a consumer class action over pay-for-delay deals with generic-drug makers will likely be the first of many settlements to come, experts say, as manufacturers wrestle with the U.S. Supreme Court’s ...read more

  • Tags: